A Research Study of CP-724,714 in Patients With HER2 Overexpressing Metastatic Breast Cancer

Clinical trial NCT00102895 · TERMINATED

Trial details

NCT number: NCT00102895
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms Neoplasm Metastasis

Start date: 2005-04-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.